Table 1.
Association between HOXC10 expression and esophageal squamous cell carcinoma clinicopathological characteristics.
| Characteristics | Number | HOXC10 mRNA expression |
p | |
|---|---|---|---|---|
| High (%) | Low (%) | |||
| Age, years | 0.441 | |||
| <60 | 33 | 15(36.59) | 18(45) | |
| ≥60 | 48 | 26(63.41) | 22(55) | |
| sex | 0.54 | |||
| Male | 52 | 25(60.98) | 27(67.5) | |
| Female | 29 | 16(39.02) | 13(32.5) | |
| Cell differentiation | 0.19 | |||
| well | 12 | 4(9.76) | 8(20) | |
| moderate | 58 | 29(70.73) | 29(72.5) | |
| poor | 11 | 8(19.51) | 3(7.5) | |
| Tumour invasion depth | 0.006 | |||
| T1 | 7 | 3(7.32) | 4(10) | |
| T2 | 23 | 6(14.63) | 17(42.5) | |
| T3 | 50 | 31(75.61) | 19(47.5) | |
| T4 | 1 | 1(2.44) | 0(0) | |
| Lymph node metastasis | 0.202 | |||
| N0 | 42 | 18(43.9) | 24(58.54) | |
| N1 | 31 | 17(41.46) | 14(35) | |
| N2 | 8 | 6(14.64) | 2(5) | |
| N3 | 0 | 0 | 0 | |
| TNM stage | 0.006 | |||
| Ⅰ | 6 | 2(4.88) | 4(10) | |
| Ⅱ | 44 | 17(41.46) | 27(67.5) | |
| Ⅲ | 31 | 22(53.66) | 9(22.5) | |
| Ⅳ | 0 | 0(0) | 0(0) | |
*P-values were calculated using Pearson's χ2 test or Fisher's exact test, as appropriate.